Pricing Log in Create free account

Belite Bio, Inc. Sponsored ADR (BLTE) vs PTC Therapeutics, Inc. (PTCT)

Belite Bio, Inc. Sponsored ADR and PTC Therapeutics, Inc. are both Biotechnology companies. Belite Bio, Inc. Sponsored ADR and PTC Therapeutics, Inc. are of similar size ($5.8B and $5.5B). Belite Bio, Inc. Sponsored ADR has the higher net margin (0.00% vs −9.17%) and the lower return on invested capital (−9.55% vs 17.7%). Across the 12 metrics below, PTC Therapeutics, Inc. leads on 7 and Belite Bio, Inc. Sponsored ADR on 5.

Valuation

Metric BLTE PTCT Biotechnology median
P/E n/m n/m 10.26
P/S n/m 4.76 9.18
P/B 7.48 n/m 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA n/m 32.37 0.65
EV/Sales n/m 5.37 8.98
Earnings yield (1.90%) (1.99%) (34.89%)
Free cash flow yield (1.16%) (4.72%) (24.52%)

Profitability

Metric BLTE PTCT Biotechnology median
Gross margin — 93.20% 65.16%
Operating margin 0.00% 12.78% 0.00%
Net margin 0.00% (9.17%) 0.00%
Free cash flow margin 0.00% (22.43%) 0.00%
Return on equity 0.00% 61.08% (50.12%)
Return on assets (21.60%) (3.62%) (45.60%)
Return on invested capital (9.55%) 17.66% 0.00%

Growth

Metric BLTE PTCT Biotechnology median
Revenue growth (TTM) — (35.05%) 6.26%
EPS growth (last fiscal year) (95.76%) 264.48% 29.88%
Revenue growth, 5-year CAGR — 35.37% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BLTE PTCT Biotechnology median
Debt to equity 0.00 (14.86) 0.00
Current ratio 33.56 3.27 4.89
Net debt to EBITDA 5.88 0.73 1.01

Dividend

Metric BLTE PTCT Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric BLTE PTCT Biotechnology median
Market cap 5.77b 5.49b 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack